SCHEMBL1126568

SCHEMBL1126568

CN(CC(=O)N(C)C)Cc1ccc(N)nc1.COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(Cn4ccnc4)cn3)c3nccnc23)c1Cl

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 20/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12678366 0.88 FGFR3 (0.70) FGFR3
SCHEMBL1126412 0.88 FGFR3 (0.72) FGFR3
SCHEMBL1126562 0.83 FGFR3 (0.77) FGFR3
SCHEMBL1126224 0.83 FGFR3 (0.74) FGFR3
SCHEMBL3315565 0.82 FGFR3 (0.51) FGFR3
SCHEMBL3313560 0.82 FGFR3 (0.51) FGFR3
SCHEMBL1126739 0.82 FGFR3 (0.82) FGFR3
SCHEMBL1126344 0.81 FGFR3 (0.61) FGFR3
SCHEMBL12678386 0.80 FGFR3 (0.85) FGFR3
SCHEMBL1126071 0.80 FGFR3 (0.71) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS Novartis AG (CH) 2011-02-16 EP claimed